Company
AdAlta Ltd
ASX:1AD
AdAlta is a clinical stage biotechnology business addressing the need for effective cellular immunotherapies for the treatment of solid cancers. The company's “East to West” cellular immunotherapy strategy is the primary driver of future growth and value creation initiatives.
45 stories · page 1 of 3
Healthcare stocks maintain clinical momentum in 2023’s March quarter
Year-to-date figures indicate the healthcare sector is up 6.13%, while the XHJ index has jumped 9.09% since this time last year.